ACOG Committee Opinion No. 415: Depot medroxyprogesterone acetate and bone effects
Obstetrics and Gynecology 112(3): 727-730
2008
ISSN/ISBN: 0029-7844 PMID: 18757687 DOI: 10.1097/aog.0b013e318188d1ecDocument Number: 203095
Document emailed within 0-6 h
Related Documents
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405Wanichsetakul, P.; Kamudhamas, A.; Watanaruangkovit, P.; Siripakarn, Y.; Visutakul, P. 2002: Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception Contraception 65(6): 407-410
2001: ACOG Committee Opinion no. 256: Committee on Obstetric Practice. Optimal goals for anesthesia care in obstetrics Obstetrics and Gynecology 97(5 Pt 1): Suppl. 1-3
Rahman, M.; Berenson, A.B. 2010: Predictors of higher bone mineral density loss and use of depot medroxyprogesterone acetate Obstetrics and Gynecology 115(1): 35-40
Babatunde, O.O.; Forsyth, J.J. 2014: Association between depot medroxyprogesterone acetate (DMPA), physical activity and bone health Journal of Bone and Mineral Metabolism 32(3): 305-311
Cundy, T.; Cornish, J.; Roberts, H.; Reid, I.R. 2002: Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception American Journal of Obstetrics and Gynecology 186(5): 978-983
Harel, Z.; Johnson, C.Cole.; Gold, M.A.; Cromer, B.; Peterson, E.; Burkman, R.; Stager, M.; Brown, R.; Bruner, A.; Coupey, S.; Hertweck, P.; Bone, H.; Wolter, K.; Nelson, A.; Marshall, S.; Bachrach, L.K. 2010: Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections Contraception 81(4): 281-291
Gai, L.; Zhang, J.; Zhang, H.; Gai, P.; Liu, Y. 2009: Effect of Depot Medroxyprogesterone Acetate (DMPA) on Bone Mineral Density in Women of Reproductive Age Journal of Reproduction and Contraception 20(1): 51-56
1993: Genetic risk and screening techniques for epithelial ovarian cancer. ACOG Committee Opinion: Committee on Gynecologic Practice. Number 117--December 1992 International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 41(3): 321-323
Modesto, W.; Bahamondes, M.V.; Bahamondes, L. 2015: Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate Journal of Women's Health 24(8): 636-640
Pongsatha, S.; Ekmahachai, M.; Chaovisitsaree, S.; Suntornlimsiri, N.; Morakote, N. 2009: Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study Journal of the Medical Association of Thailand 92(10): 1263-1267
Modesto, W.; Bahamondes, M.V.; Silva dos Santos, P.; Fernandes, A.; Dal'Ava, N.; Bahamondes, L. 2014: Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetate European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 19(4): 244-249
Yang, L.; Hao, Y.; Hu, J.; Kelly, D.; Li, H.; Brown, S.; Tasker, C.; Roche, N.E.; Chang, T.L.; Pei, Z. 2019: Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women Emerging Microbes and Infections 8(1): 197-210
Harel, Z.; Wolter, K.; Gold, M.A.; Cromer, B.; Bruner, A.; Stager, M.; Bachrach, L.; Hertweck, P.; Nelson, A.; Nelson, D.; Coupey, S.; Johnson, C.C.; Burkman, R.; Bone, H. 2010: Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study Journal of Pediatric and Adolescent Gynecology 23(4): 209-214
2006: ACOG Committee Opinion No. 352: Innovative practice: ethical guidelines Obstetrics and Gynecology 108(6): 1589-1595
2004: ACOG Committee Opinion #300: Cervical cancer screening in adolescents Obstetrics and Gynecology 104(4): 885-889
2006: ACOG Committee Opinion: Number 345, October 2006: vulvodynia Obstetrics and Gynecology 108(4): 1049-1052
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Gai, L.; Zhang, J.; Zhang, H.; Gai, P.; Zhou, L.; Liu, Y. 2011: The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age Contraception 83(3): 218-222
Gai, L.; Zhang, J.; Zhang, H.; Gai, P.; Zhou, L.; Liu, Y. 2011: The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age Contraception 83(3): 218-222